US Stock MarketDetailed Quotes
SCPX Scorpius Holdings
- 0.660
- 0.0000.00%
Close Nov 22 16:00 ET
- 0.640
- -0.020-2.98%
Post 17:34 ET
2.86MMarket Cap-12P/E (TTM)
0.670High0.640Low58.61KVolume0.651Open0.660Pre Close38.22KTurnover1.60%Turnover RatioLossP/E (Static)4.33MShares110.00052wk High0.10P/B2.41MFloat Cap0.62652wk Low--Dividend TTM3.66MShs Float214060.000Historical High--Div YieldTTM4.55%Amplitude0.626Historical Low0.652Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Scorpius Holdings Stock Forum
Scorpius Introduces Scorpius Ventures To Advance U.S. Biotech Innovation With Adaptive Equity-Based Onshoring Model
📊⚡️📊
$PS International Group (PSIG.US)$ Fridays unusual volume along with it having less than 2% short volume in that total points to a equities sale happening at $2.82 about 89 days ago. This would mean on Monday the buyback would happen that would take it to the ending sale price of $1.55. Whether this is a quick buyback or slow is unknown. The goal is a buy-in at .56 and a sell at 1.55 with a...
04/11/2024 - 20:30
DURHAM, N.C., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization ("CDMO"), today announced a partnership with Celltheon Corporation to provide cell line developm...
Scorpius Holdings Announces Implementation of New Cost Savings Measures Expected to Save Over $2 Million Annually
Scorpius Holdings (NYSE American: SCPX) has announced strategic cost-saving measures expected to generate over $2 million in annual savings. The initiatives include divesting non-core assets and implementing operational efficiency programs. The company aims to strengthen its financial position and focus on high-margin growth areas within its sales pi...
Scorpius Holdings Announces Partnership with U.S. Biotech Company
Scorpius Holdings, Inc (NYSE American: SCPX) has announced a strategic partnership with a U.S.-based biotech company. The agreement involves the biotech company working with Scorpius' program management team and plans to transfer a research cell bank (RCB) to Scorpius' facilities in San Antonio, TX for future biomanufacturing activities.
CEO Jeff Wolf emphasized that this partnership demonstrates S...
No comment yet